BACKGROUND: There is some evidence that plasma insulin levels might influence ovarian cancer risk. Glycaemic index (GI) and glycaemic load (GL) are measures that allow the carbohydrate content of individual foods to be classified according to their postprandial glycaemic effects and hence their effects on circulating insulin levels. Therefore, we examined ovarian cancer risk in association with GI and GL, and intake of dietary carbohydrate and sugar. METHODS: The study was conducted in a prospective cohort of 49 613 Canadian women enrolled in the National Breast Screening Study (NBSS) who completed a self-administered food-frequency questionnaire (FFQ) between 1980 and 1985. Linkages to national mortality and cancer databases yielded data on deaths and cancer incidence, with follow-up ending between 1998 and 2000. Data from the FFQ were used to estimate overall GI and GL, and Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between energy-adjusted quartile levels of GL, overall GI, total carbohydrates, total sugar and ovarian cancer risk. RESULTS: During a mean 16.4 years of follow-up, we observed 264 incident ovarian cancer cases. GI and total carbohydrate and sugar intakes were not associated with ovarian cancer risk in the total cohort. GL was positively associated with a 72% increase in risk of ovarian cancer (HR=1.72, 95% CI=1.13-2.62, Ptrend=0.01) and the magnitude of the association was slightly greater among postmenopausal (HR=1.89, 95% CI=0.98-3.65, Ptrend=0.03) than among premenopausal women (HR=1.64, 95% CI=0.95-2.88, Ptrend=0.07). CONCLUSIONS: Our data suggest that consumption of diets with high GL values may be associated with increased risk of ovarian cancer.
BACKGROUND: There is some evidence that plasma insulin levels might influence ovarian cancer risk. Glycaemic index (GI) and glycaemic load (GL) are measures that allow the carbohydrate content of individual foods to be classified according to their postprandial glycaemic effects and hence their effects on circulating insulin levels. Therefore, we examined ovarian cancer risk in association with GI and GL, and intake of dietary carbohydrate and sugar. METHODS: The study was conducted in a prospective cohort of 49 613 Canadian women enrolled in the National Breast Screening Study (NBSS) who completed a self-administered food-frequency questionnaire (FFQ) between 1980 and 1985. Linkages to national mortality and cancer databases yielded data on deaths and cancer incidence, with follow-up ending between 1998 and 2000. Data from the FFQ were used to estimate overall GI and GL, and Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between energy-adjusted quartile levels of GL, overall GI, total carbohydrates, total sugar and ovarian cancer risk. RESULTS: During a mean 16.4 years of follow-up, we observed 264 incident ovarian cancer cases. GI and total carbohydrate and sugar intakes were not associated with ovarian cancer risk in the total cohort. GL was positively associated with a 72% increase in risk of ovarian cancer (HR=1.72, 95% CI=1.13-2.62, Ptrend=0.01) and the magnitude of the association was slightly greater among postmenopausal (HR=1.89, 95% CI=0.98-3.65, Ptrend=0.03) than among premenopausal women (HR=1.64, 95% CI=0.95-2.88, Ptrend=0.07). CONCLUSIONS: Our data suggest that consumption of diets with high GL values may be associated with increased risk of ovarian cancer.
Authors: Tracy E Crane; Beman R Khulpateea; David S Alberts; Karen Basen-Engquist; Cynthia A Thomson Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-10-18 Impact factor: 4.254
Authors: Nitin Shivappa; James R Hébert; Lisa E Paddock; Lorna Rodriguez-Rodriguez; Sara H Olson; Elisa V Bandera Journal: Nutrition Date: 2017-09-23 Impact factor: 4.008
Authors: Rose G Radin; Julie R Palmer; Lynn Rosenberg; Shiriki K Kumanyika; Lauren A Wise Journal: Am J Clin Nutr Date: 2010-03-03 Impact factor: 7.045
Authors: Nataša Tasevska; Li Jiao; Amanda J Cross; Victor Kipnis; Amy F Subar; Albert Hollenbeck; Arthur Schatzkin; Nancy Potischman Journal: Int J Cancer Date: 2011-05-25 Impact factor: 7.396
Authors: Stephanie Materese George; Susan T Mayne; Michael F Leitzmann; Yikyung Park; Arthur Schatzkin; Andrew Flood; Albert Hollenbeck; Amy F Subar Journal: Am J Epidemiol Date: 2008-12-18 Impact factor: 4.897
Authors: Nitin Shivappa; James R Hébert; Valentina Rosato; Marta Rossi; Maurizio Montella; Diego Serraino; Carlo La Vecchia Journal: Cancer Causes Control Date: 2016-06-04 Impact factor: 2.506
Authors: Bo Qin; Patricia G Moorman; Anthony J Alberg; Jill S Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward S Peters; Ann G Schwartz; Paul Terry; Joellen M Schildkraut; Elisa V Bandera Journal: Br J Nutr Date: 2015-12-16 Impact factor: 3.718
Authors: Melony G King; Sara H Olson; Lisa Paddock; Urmila Chandran; Kitaw Demissie; Shou-En Lu; Niyati Parekh; Lorna Rodriguez-Rodriguez; Elisa V Bandera Journal: BMC Cancer Date: 2013-02-27 Impact factor: 4.430